Share buyback program – Ipsen reporting from 11 July to 15 July 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
Attachment
IPSEN – Buy-back programme – Art 5 of MAR – Week 49- 2025
Ipsen – November 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
IPSEN – Buy-back programme – Art 5 of MAR – Week 48 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 47 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 46 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 45 – 2025
Ipsen – October 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
IPSEN – Buy-back programme – Art 5 of MAR – Week 44 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 43 – 2025
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline